SCHEMBL18607341

SCHEMBL18607341

CN(C)CCN(C)c1cc(OC(F)F)c(Nc2nccc(C(=N)c3ccccc3O)n2)cc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.41
KCNH2 Q12809 2/20 0.36
ALK Q9UM73 3/20 0.35
EML4 Q9HC35 2/20 0.35
MLNR O43193 1/20 0.35
KDM1A O60341 1/20 0.35
ABCB11 O95342 1/20 0.35
ERBB2 P04626 1/20 0.35
INSR P06213 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
DRD2 P14416 1/20 0.35
NQO2 P16083 1/20 0.35
ADRA2C P18825 1/20 0.35
DRD1 P21728 1/20 0.35
ERBB3 P21860 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19336965 0.84 EGFR (0.48) EGFRKCNH2ALKEML4MLNR
SCHEMBL19337022 0.83 EGFR (0.47) EGFRKCNH2ALKEML4MLNR
SCHEMBL18607340 0.77 EGFR (0.49) EGFRKCNH2ALKEML4MLNR
SCHEMBL17683113 0.77 EGFR (0.60) EGFRKCNH2ALKEML4MLNR
SCHEMBL30459829 0.77 EGFR (0.60) EGFRKCNH2ALKEML4MLNR
SCHEMBL17683231 0.77 EGFR (0.60) EGFRKCNH2ALKEML4MLNR
SCHEMBL17683085 0.76 EGFR (0.62) EGFRKCNH2ALKEML4MLNR
SCHEMBL18607355 0.75 EGFR (0.59) EGFRKCNH2ALKEML4MLNR
SCHEMBL19254834 0.75 EGFR (0.50) EGFRKCNH2ALKEML4MLNR
SCHEMBL18607059 0.75 EGFR (0.48) EGFRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017035753-A1 2-ARYLAMINO PYRIDINE, PYRIDINE OR TRIAZINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF 无锡双良生物科技有限公司 2017-03-09 WO disclosed